SEC Form 4 · accession 0001127602-18-005997
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
F Samuel Eberts III
Officer — Chief Legal Officer, Secretary
Period of report
Feb 12, 2018
Accepted (ET)
Feb 14, 2018 · 2:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock OptionsF1,F2 | $168.49 | Feb 12, 2018 | A | 2,700 | A | Feb 12, 2019 | Feb 11, 2028 | Common Stock | 2,700 | 2,700 | D |
| Restricted Stock UnitF5,F3,F4 | — | Feb 12, 2018 | A | 700 | A | — | — | Common Stock | 700 | 2,278 | D |
Explanation of responses
- F1Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- F2The option vests in three equal installments beginning on the date reflected in this column.
- F3Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F4The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2019.
- F5This number reflects the aggregate number of Restricted Stock Units held by the reporting person.